Poster Presentations

医学
作者
To describe the clinical syndromes of MOGAD at presentation and association of steroid therapy duration with relapse.
出处
期刊:Developmental Medicine & Child Neurology [Wiley]
卷期号:67 (S1): 23-136
标识
DOI:10.1111/dmcn.16181
摘要

Objectives: To describe the clinical syndromes of MOGAD at presentation and association of steroid therapy duration with relapse.Methods: All paediatric patients (<16 years of age at time of initial positive anti-MOG antibody testing) in the 2019-2023 period as reported by the West of Scotland Neuroimmunology Laboratory were identified and their medical records retrospectively analyzed.Results: We identified twenty-nine patients with anti-MOG antibodies, twenty-five of whom had MOGAD-related clinical syndromes at first presentation and twenty-two of which were treated with immunosuppression.Of these twenty-two patients 34.5% had acute disseminated encephalomyelitis (mean age 6.8 years at first presentation), 27.5% had optic neuritis (mean age 10.9 years) and 13.8% had transverse myelitis (mean age 9.75 years).The twenty-two MOGAD patients given immunosuppression (IV methylprednisolone for three days in all cases) had an average length of steroid treatment of 47.1 days (range 3--90) and seven patients had a clinical relapse (31%).77.2% of MOGAD patients had magnetic resonance imaging findings consistent with their clinical MOGAD syndromes at initial presentation, and the remainder had unremarkable imaging.Longer duration of initial steroid treatment (>42 days) was found to be associated with no or single relapses, whereas shorter duration (average 24 days) was associated with more than one relapse in those patients who suffered from a relapse.The range of the number of relapses were 0-3 and only one patient had a relapse with a clinically different syndrome to their previous presentation. Conclusions:The majority (75%) of MOGAD patients present with clinical syndromes that are typical of what is understood of the disease process, but some anti-MOG antibodies were seen in patients without MOGAD or in patients with MOGAD-related syndromes that spontaneously improved without immunosuppression.Longer courses of steroids are associated with a lower number of relapses, although further data is required to verify these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
田様的应助被xxxg郭采纳,获得10
2秒前
汉堡包的应助被cc采纳,获得10
2秒前
虾米君完成签到,获得积分10
2秒前
3秒前
溜溜梅棒棒棒完成签到,获得积分10
3秒前
FashionBoy的应助被motal采纳,获得10
3秒前
春风失意发布了新的文献求助10
4秒前
耶稣与梦完成签到,获得积分10
5秒前
Pao完成签到,获得积分10
5秒前
ZXheng完成签到,获得积分10
6秒前
6秒前
8秒前
DW的应助被汤易文采纳,获得10
8秒前
8秒前
mugi3055完成签到 ,获得积分10
8秒前
zhangpeiguo完成签到,获得积分10
10秒前
Ariel发布了新的文献求助10
10秒前
10秒前
11秒前
沉默笑翠完成签到,获得积分10
12秒前
爆米花的应助被youknowdcf采纳,获得10
13秒前
13秒前
西陆发布了新的文献求助10
13秒前
JeanetteJin发布了新的文献求助10
14秒前
14秒前
哒哒完成签到,获得积分10
14秒前
14秒前
cc完成签到,获得积分10
15秒前
蔡翌文完成签到 ,获得积分10
15秒前
NASA_FAST发布了新的文献求助30
15秒前
zhouyang完成签到,获得积分10
16秒前
嘟哒哒发布了新的文献求助10
16秒前
二马三乡发布了新的文献求助10
16秒前
ddiou发布了新的文献求助10
17秒前
nofearrrrrr完成签到,获得积分10
17秒前
18秒前
852的应助被JeanetteJin采纳,获得10
18秒前
泛舟荡春心完成签到,获得积分10
18秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177667
求助须知:如何正确求助?哪些是违规求助? 9568537
关于积分的说明 21799700
捐赠科研通 7772307
什么是DOI,文献DOI怎么找? 3432429
关于科研通互助平台的介绍 2556651
邀请新用户注册赠送积分活动 2478011